Latest filing published 08 Sept 2026 for Perspective Therapeutics, Inc., €216k.
Not enough history yet: 0 closed purchases, at least 2 are needed.
All filings by Lantheus Alpha Therapy, LLC on record concern Perspective Therapeutics, Inc. Between 6 March 2024 and 4 September 2026, the trades on record add up to 6 filings.
The open-market side counts 1 purchase for €52.9M alongside 5 sales for €1.1M. Purchases outweigh sales by €51.8M. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. In 2026 alone, the filings show no purchases and 5 sales.
On 8 September 2026 came the latest disclosure, an open-market sale for €216k in Perspective Therapeutics, Inc. The most recent open-market purchase was published on 8 March 2024, 960 days ago. Typically, a trade is published a median of 4 days after it takes place. Section 16 rules allow two business days to file each Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 of 6 declarations